434 related articles for article (PubMed ID: 26046399)
21. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma.
Narsinh KH; Perez E; Haddad AF; Young JS; Savastano L; Villanueva-Meyer JE; Winkler E; de Groot J
Curr Neurol Neurosci Rep; 2024 May; 24(5):123-139. PubMed ID: 38578405
[TBL] [Abstract][Full Text] [Related]
22. Efficient Delivery of Lomitapide using Hybrid Membrane-Coated Tetrahedral DNA Nanostructures for Glioblastoma Therapy.
Song M; Tian J; Wang L; Dong S; Fu K; Chen S; Liu C
Adv Mater; 2024 Jun; 36(24):e2311760. PubMed ID: 38569065
[TBL] [Abstract][Full Text] [Related]
23. PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review.
Fana M; Gallien J; Srinageshwar B; Dunbar GL; Rossignol J
Int J Nanomedicine; 2020; 15():2789-2808. PubMed ID: 32368055
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies.
Karlsson J; Luly KM; Tzeng SY; Green JJ
Adv Drug Deliv Rev; 2021 Dec; 179():113999. PubMed ID: 34715258
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools.
Cela I; Capone E; Trevisi G; Sala G
Semin Cancer Biol; 2024 Jun; 101():25-43. PubMed ID: 38754752
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.
Chowdhury FA; Hossain MK; Mostofa AGM; Akbor MM; Bin Sayeed MS
Biomed Res Int; 2018; 2018():4010629. PubMed ID: 29651429
[TBL] [Abstract][Full Text] [Related]
27. Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy.
Gregory JV; Kadiyala P; Doherty R; Cadena M; Habeel S; Ruoslahti E; Lowenstein PR; Castro MG; Lahann J
Nat Commun; 2020 Nov; 11(1):5687. PubMed ID: 33173024
[TBL] [Abstract][Full Text] [Related]
28. An In Silico Investigation of Pharmacological Modulators and Inflammasomes in Glioblastoma Multiforme.
Parveen R; Kashif M; Srinivasan H; Khan J; Yousif A; Ghataty DS; Ali N; Attia SM; Waseem M
Appl Biochem Biotechnol; 2024 May; 196(5):2771-2797. PubMed ID: 37466884
[TBL] [Abstract][Full Text] [Related]
29. Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours.
Karlsson J; Rui Y; Kozielski KL; Placone AL; Choi O; Tzeng SY; Kim J; Keyes JJ; Bogorad MI; Gabrielson K; Guerrero-Cazares H; Quiñones-Hinojosa A; Searson PC; Green JJ
Nanoscale; 2019 Nov; 11(42):20045-20057. PubMed ID: 31612183
[TBL] [Abstract][Full Text] [Related]
30. Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment.
Cai Q; Li X; Xiong H; Fan H; Gao X; Vemireddy V; Margolis R; Li J; Ge X; Giannotta M; Hoyt K; Maher E; Bachoo R; Qin Z
Nat Commun; 2023 Aug; 14(1):4934. PubMed ID: 37582846
[TBL] [Abstract][Full Text] [Related]
31. Intranasal delivery of sunitinib: A new therapeutic approach for targeting angiogenesis of glioblastoma.
Seidkhani E; Moradi F; Rustamzadeh A; Simorgh S; Shirvalilou S; Mehdizadeh M; Dehghani H; Akbarnejad Z; Motevalian M; Gorgich EAC
Toxicol Appl Pharmacol; 2023 Dec; 481():116754. PubMed ID: 37956929
[TBL] [Abstract][Full Text] [Related]
32. Exosomes: Their role in the diagnosis, progression, metastasis, and treatment of glioblastoma.
Mousavikia SN; Darvish L; Bahreyni Toossi MT; Azimian H
Life Sci; 2024 Aug; 350():122743. PubMed ID: 38806071
[TBL] [Abstract][Full Text] [Related]
33. Molecular Mechanisms of Treatment Resistance in Glioblastoma.
Ou A; Yung WKA; Majd N
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396284
[TBL] [Abstract][Full Text] [Related]
34. Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors.
Calabrese G; De Luca G; Nocito G; Rizzo MG; Lombardo SP; Chisari G; Forte S; Sciuto EL; Conoci S
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769212
[TBL] [Abstract][Full Text] [Related]
35. Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles.
Huang X; Mu N; Ding Y; Huang R; Wu W; Li L; Chen T
J Control Release; 2024 Feb; 366():194-203. PubMed ID: 38142965
[TBL] [Abstract][Full Text] [Related]
36. Blood brain barrier: a challenge for effectual therapy of brain tumors.
Bhowmik A; Khan R; Ghosh MK
Biomed Res Int; 2015; 2015():320941. PubMed ID: 25866775
[TBL] [Abstract][Full Text] [Related]
37. Fruit-Derived Extracellular-Vesicle-Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy.
Chen J; Pan J; Liu S; Zhang Y; Sha S; Guo H; Wang X; Hao X; Zhou H; Tao S; Wang Y; Fan JB
Adv Mater; 2023 Nov; 35(45):e2304187. PubMed ID: 37589312
[TBL] [Abstract][Full Text] [Related]
38. Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment.
Pandey N; Anastasiadis P; Carney CP; Kanvinde PP; Woodworth GF; Winkles JA; Kim AJ
Adv Drug Deliv Rev; 2022 Sep; 188():114415. PubMed ID: 35787387
[TBL] [Abstract][Full Text] [Related]
39. New trends in brain tumor immunity with the opportunities of lymph nodes targeted drug delivery.
Qi Y; Xiong W; Chen Q; Ye Z; Jiang C; He Y; Ye Q
J Nanobiotechnology; 2023 Aug; 21(1):254. PubMed ID: 37542241
[TBL] [Abstract][Full Text] [Related]
40. Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma.
Tincu Iurciuc CE; Andrițoiu CV; Popa M; Ochiuz L
Polymers (Basel); 2023 Oct; 15(19):. PubMed ID: 37836018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
